BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 10643211)

  • 41. [Diabetes mellitus].
    Kawano M; Kanazawa Y
    Nihon Rinsho; 2000 Feb; 58(2):421-5. PubMed ID: 10707569
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Drug therapy in subjects with impaired glucose tolerance].
    Kawamori R; Yoshii H
    Nihon Rinsho; 1996 Oct; 54(10):2750-3. PubMed ID: 8914439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).
    Wolffenbuttel BH; van Haeften TW
    Drugs; 1995 Aug; 50(2):263-88. PubMed ID: 8521759
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral combination therapy for type 2 diabetes.
    Charpentier G
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S70-6. PubMed ID: 12324989
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Current and future aspects of oral antidiabetic agents in type 2 diabetes].
    Rybka J
    Vnitr Lek; 2001 May; 47(5):285-90. PubMed ID: 11395869
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Constructing an algorithm for managing type 2 diabetes. Focus on role of the thiazolidinediones.
    Wyne KL; Drexler AJ; Miller JL; Bell DS; Braunstein S; Nuckolls JG
    Postgrad Med; 2003 May; Spec No():63-72. PubMed ID: 12785133
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Utilization of oral hypoglycemic agents in a drug-insured U.S. population.
    Boccuzzi SJ; Wogen J; Fox J; Sung JC; Shah AB; Kim J
    Diabetes Care; 2001 Aug; 24(8):1411-5. PubMed ID: 11473078
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral agents in managing diabetes mellitus in children and adolescents.
    Jacobson-Dickman E; Levitsky L
    Pediatr Clin North Am; 2005 Dec; 52(6):1689-703. PubMed ID: 16301089
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of type 2 diabetes mellitus.
    Feinglos MN; Bethel MA
    Med Clin North Am; 1998 Jul; 82(4):757-90. PubMed ID: 9706120
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thiazolidinediones: a new class of antidiabetic drugs.
    Day C
    Diabet Med; 1999 Mar; 16(3):179-92. PubMed ID: 10227562
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical difference between thiazolidinediones and biguanides].
    Hotta N
    Nihon Rinsho; 2001 Nov; 59(11):2219-27. PubMed ID: 11712411
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New insights into antidiabetic drugs: Possible applications in cancer treatment.
    Shafiei-Irannejad V; Samadi N; Salehi R; Yousefi B; Zarghami N
    Chem Biol Drug Des; 2017 Dec; 90(6):1056-1066. PubMed ID: 28456998
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety of drugs commonly used to treat hypertension, dyslipidemia, and Type 2 diabetes (the metabolic syndrome): part 2.
    Marcus AO
    Diabetes Technol Ther; 2000; 2(2):275-81. PubMed ID: 11469270
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Type 2 diabetes mellitus: Which place for thiazolidinediones in the therapeutic strategy?].
    Halimi S
    Diabetes Metab; 2001 Apr; 27(2 Pt 2):287-93. PubMed ID: 11452223
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment update: thiazolidinediones in combination with metformin for the treatment of type 2 diabetes.
    Stafford JM; Elasy T
    Vasc Health Risk Manag; 2007; 3(4):503-10. PubMed ID: 17969380
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reappraisal of the pharmacologic approach to treatment of type 2 diabetes mellitus.
    Weissman P
    Am J Cardiol; 2002 Sep; 90(5A):42G-50G. PubMed ID: 12231078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Challenges Related to Glycemic Control in Type 2 Diabetes Mellitus Patients.
    Kheirandish M; Mahboobi H; Yazdanparast M; Kamal MA
    Curr Drug Metab; 2017; 18(2):157-162. PubMed ID: 28093996
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combining sulfonylureas and other oral agents.
    Riddle M
    Am J Med; 2000 Apr; 108 Suppl 6a():15S-22S. PubMed ID: 10764846
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics, tolerability, and fructosamine-lowering effect of a novel, controlled-release formulation of alpha-lipoic acid.
    Evans JL; Heymann CJ; Goldfine ID; Gavin LA
    Endocr Pract; 2002; 8(1):29-35. PubMed ID: 11951812
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treating diabetes using oral agents.
    Malik T; Trence DL
    Prim Care; 2003 Sep; 30(3):527-41. PubMed ID: 14692199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.